The mission of CBR Pharma Insights is to empower companies within the pharmaceutical industry to make the best business decisions possible through providing them with quality, innovative, strategic market research solutions.CBRâs market research solutions are focused on being both proactive reactive in identifying, evaluating, and assessing the key strategic R&D and commercial issues within the pharmaceutical industry.

Page

PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets

By CBR Pharma Insights | Pharmaceuticals and Healthcare | Jun 2018 | Page 265

PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape,....

USD 2995 View Report

The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players

By CBR Pharma Insights | Pharmaceuticals and Healthcare | May 2018 | Page 140

The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players GBI Research’s latest report, The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations....

USD 2995 View Report

Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018

By CBR Pharma Insights | Pharmaceuticals and Healthcare | Mar 2018 | Page 104

Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018 GBI Research’s latest report: “Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel....

USD 2995 View Report

Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies

By CBR Pharma Insights | Pharmaceuticals and Healthcare | Feb 2018 | Page 106

Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies....

USD 2995 View Report

Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis

By CBR Pharma Insights | Pharmaceuticals and Healthcare | Jan 2018 | Page 79

Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis GBI Researchs latest report: Gene Therapies:....

USD 2995 View Report